{"id":12334,"date":"2024-08-06T14:05:07","date_gmt":"2024-08-06T12:05:07","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12334"},"modified":"2026-03-03T10:36:42","modified_gmt":"2026-03-03T09:36:42","slug":"blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/","title":{"rendered":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9"},"content":{"rendered":"\n<p><em>\u00c0 propos du Moniteur de la sant\u00e9 d\u2019Interpharma: pour le Moniteur de la sant\u00e9, on pose \u00e0 des citoyen-ne-s suisses des questions li\u00e9es au syst\u00e8me de sant\u00e9 suisse. Interpharma mandate gfs.bern pour cette \u00e9tude annuelle depuis 1997. Dans une s\u00e9rie de blogs en plusieurs parties, nous abordons et \u00e9clairons les th\u00e8mes cl\u00e9s de l\u2019\u00e9tude de cette ann\u00e9e.<\/em><em><\/em><\/p>\n\n\n\n<p><em><strong>\u00c0 l\u2019\u00e9chelle de la Suisse, les citoyen-ne-s reconnaissent et appr\u00e9cient la haute qualit\u00e9 du syst\u00e8me de sant\u00e9. Mais une prise en charge sanitaire de premier ordre est li\u00e9e \u00e0 des co\u00fbts qui repr\u00e9sentent une lourde charge pour une partie des habitant-e-s de notre pays. Cependant, les r\u00e9pondant-e-s attachent plus d\u2019importance \u00e0 la qualit\u00e9 du syst\u00e8me de sant\u00e9 qu\u2019\u00e0 ses co\u00fbts. Des mesures visant \u00e0 les faire baisser, par exemple une r\u00e9duction du catalogue des prestations, ne sont pas majoritaires. Le tableau est diff\u00e9rent en Suisse romande: la pression des co\u00fbts y est plus lourde et on y est plus dispos\u00e9 au compromis sur des mesures visant \u00e0 r\u00e9duire les co\u00fbts de sant\u00e9.&nbsp;&nbsp; <\/strong><\/em><em><strong><\/strong><\/em><\/p>\n\n\n\n<p>Le Moniteur de la sant\u00e9 2024 d\u2019Interpharma montre que le \u00abR\u00f6stigraben\u00bb se creuse dans diff\u00e9rents domaines pour ce qui est des questions relatives \u00e0 la sant\u00e9. Ainsi par exemple au niveau de l\u2019\u00e9valuation de la qualit\u00e9 du syst\u00e8me de sant\u00e9: \u00e0 l\u2019\u00e9chelle de la Suisse, environ trois quarts des personnes interrog\u00e9es \u00e9valuent la qualit\u00e9 du syst\u00e8me de sant\u00e9 suisse comme \u00abbonne\u00bb ou \u00abtr\u00e8s bonne\u00bb (73%), 24% comme \u00abplut\u00f4t bonne\u00bb. Les avis n\u00e9gatifs continuent \u00e0 \u00eatre quasiment inexistants (3%). Ce sont 25% des personnes interrog\u00e9es qui r\u00e9pondent \u00abtr\u00e8s bonne\u00bb, soit de m\u00eame qu\u2019en 2022 le taux le plus \u00e9lev\u00e9 depuis le d\u00e9but des enqu\u00eates. Les r\u00e9pondant-e-s sont donc extr\u00eamement satisfait-e-s de la qualit\u00e9 du syst\u00e8me de sant\u00e9.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/08\/01f-1024x695.png\" alt=\"\" class=\"wp-image-25307\"\/><\/figure>\n\n\n\n<p>Mais des diff\u00e9rences nettes apparaissent entre les r\u00e9gions linguistiques: tandis qu\u2019une claire majorit\u00e9 des habitant-e-s de Suisse al\u00e9manique et italophone jugent la qualit\u00e9 du syst\u00e8me de sant\u00e9 comme \u00abbonne\u00bb \u00e0 \u00abtr\u00e8s bonne\u00bb (DCH: 83%, ICH: 76%), les romand-e-s en sont proportionnellement moins satisfait-e-s (46% bonne\/tr\u00e8s bonne).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/08\/02f-1024x695.png\" alt=\"\" class=\"wp-image-25310\"\/><\/figure>\n\n\n\n<p>Le \u00abR\u00f6stigraben\u00bb est clair \u00e9galement au sujet des co\u00fbts. Des normes de qualit\u00e9 \u00e9lev\u00e9es vont de pair avec des co\u00fbts \u00e9lev\u00e9s. Rapport\u00e9s au PIB, les co\u00fbts de sant\u00e9 de la Suisse ne sont cependant aucunement les plus \u00e9lev\u00e9s compar\u00e9s \u00e0 ceux d\u2019autres pays: les d\u00e9penses du syst\u00e8me de sant\u00e9 sont plus \u00e9lev\u00e9es aux \u00c9tats-Unis, en Allemagne, en France, au Japon, en Autriche et en Grande-Bretagne que chez nous. [1]N\u00e9anmoins, les co\u00fbts sont probl\u00e9matiques pour une partie de la population suisse. \u00c0 long terme, la charge des co\u00fbts ressentie en Suisse al\u00e9manique et italophone est inf\u00e9rieure \u00e0 la moyenne. En d\u00e9pit de la charge financi\u00e8re et du scepticisme \u00e0 l\u2019\u00e9gard de l\u2019\u00e9volution future des co\u00fbts du syst\u00e8me de sant\u00e9, \u00e0 l\u2019\u00e9chelle de la Suisse, la population ne souhaite pas renoncer au niveau de prestations existant. La disposition \u00e0 accepter des mesures n\u00e9cessaires pour faire baisser les co\u00fbts a de plus en plus recul\u00e9 ces derni\u00e8res ann\u00e9es. On ne voit actuellement pas d\u2019approches de solutions majoritaires. C\u2019est ainsi que trois quarts des personnes interrog\u00e9es rejettent cat\u00e9goriquement une \u00e9ventuelle r\u00e9duction du catalogue des prestations.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/08\/11f-1024x790.png\" alt=\"\" class=\"wp-image-25313\"\/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p>Le tableau est diff\u00e9rent si l\u2019on observe la seule Suisse romande: depuis 2021, la charge financi\u00e8re ressentie y est en augmentation compar\u00e9e au reste de la Suisse. On y constate \u00e9galement plus d\u2019optimisme au sujet de l\u2019\u00e9volution future des co\u00fbts ainsi qu\u2019une plus grande disposition au compromis sur des mesures visant \u00e0 faire baisser les co\u00fbts du syst\u00e8me de sant\u00e9. C\u2019est ainsi que deux tiers des personnes interrog\u00e9es pourraient accepter une diminution des prestations de l\u2019assurance de base si cela faisait baisser les co\u00fbts.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/08\/12-1024x837.png\" alt=\"\" class=\"wp-image-25316\"\/><\/figure>\n\n\n\n<p>[1]<sup> <\/sup>OECD (2024), Health spending (indicator): https:\/\/data.oecd.org\/healthres\/health-spending.<\/p>\n\n\n\n<p><em><em>Cet article fait partie d\u2019une s\u00e9rie de blogs en plusieurs parties sur le syst\u00e8me de sant\u00e9 suisse. Vous trouverez plus d\u2019informations \u00e0 ce sujet dans le Moniteur de la sant\u00e9 d\u2019Interpharma pour lequel Interpharma mandate gfs.bern chaque ann\u00e9e.<\/em><\/em><\/p>\n\n\n\n<p><strong><a href=\"https:\/\/interpharma.ch\/blog\/serie-de-blogs-sur-le-moniteur-de-la-sante-2024-dinterpharma-partie-2-la-population-suisse-apprecie-la-qualite-du-systeme-de-sante-suisse\/?lang=fr\">vers la partie 2 de la s\u00e9rie de blogs<\/a><\/strong><\/p>\n\n\n\n<p><strong><a href=\"https:\/\/interpharma.ch\/?p=25408&amp;lang=fr\">vers la partie 3 de la s\u00e9rie de blogs<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c0 propos du Moniteur de la sant\u00e9 d\u2019Interpharma: pour le Moniteur de la sant\u00e9, on pose \u00e0 des citoyen-ne-s suisses des questions li\u00e9es au syst\u00e8me de sant\u00e9 suisse. Interpharma mandate gfs.bern pour cette \u00e9tude annuelle depuis 1997. Dans une s\u00e9rie de blogs en plusieurs parties, nous abordons et \u00e9clairons les th\u00e8mes cl\u00e9s de l\u2019\u00e9tude de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":833,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[130,131],"class_list":["post-12334","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-pharmastandort-2030-fr","tag-politique"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9 - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9\" \/>\n<meta property=\"og:description\" content=\"\u00c0 propos du Moniteur de la sant\u00e9 d\u2019Interpharma: pour le Moniteur de la sant\u00e9, on pose \u00e0 des citoyen-ne-s suisses des questions li\u00e9es au syst\u00e8me de sant\u00e9 suisse. Interpharma mandate gfs.bern pour cette \u00e9tude annuelle depuis 1997. Dans une s\u00e9rie de blogs en plusieurs parties, nous abordons et \u00e9clairons les th\u00e8mes cl\u00e9s de l\u2019\u00e9tude de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-06T12:05:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:36:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"791\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9\",\"datePublished\":\"2024-08-06T12:05:07+00:00\",\"dateModified\":\"2026-03-03T09:36:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\"},\"wordCount\":768,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg\",\"keywords\":[\"Pharmastandort 2030\",\"Politique\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\",\"url\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\",\"name\":\"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9 - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg\",\"datePublished\":\"2024-08-06T12:05:07+00:00\",\"dateModified\":\"2026-03-03T09:36:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg\",\"width\":550,\"height\":791},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9 - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/","og_locale":"fr_FR","og_type":"article","og_title":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9","og_description":"\u00c0 propos du Moniteur de la sant\u00e9 d\u2019Interpharma: pour le Moniteur de la sant\u00e9, on pose \u00e0 des citoyen-ne-s suisses des questions li\u00e9es au syst\u00e8me de sant\u00e9 suisse. Interpharma mandate gfs.bern pour cette \u00e9tude annuelle depuis 1997. Dans une s\u00e9rie de blogs en plusieurs parties, nous abordons et \u00e9clairons les th\u00e8mes cl\u00e9s de l\u2019\u00e9tude de [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/","og_site_name":"Interpharma","article_published_time":"2024-08-06T12:05:07+00:00","article_modified_time":"2026-03-03T09:36:42+00:00","og_image":[{"width":550,"height":791,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9","datePublished":"2024-08-06T12:05:07+00:00","dateModified":"2026-03-03T09:36:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/"},"wordCount":768,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg","keywords":["Pharmastandort 2030","Politique"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/","url":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/","name":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9 - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg","datePublished":"2024-08-06T12:05:07+00:00","dateModified":"2026-03-03T09:36:42+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Titelbild-Gesundheitsmonitor-2024-D.jpg","width":550,"height":791},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/blog\/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"S\u00e9rie de blogs sur le Moniteur de la sant\u00e9 2024 d\u2019Interpharma, partie 1: \u00abR\u00f6stigraben\u00bb de plus en plus marqu\u00e9 sur les questions de sant\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12334"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12334\/revisions"}],"predecessor-version":[{"id":12335,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12334\/revisions\/12335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/833"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12334"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}